PETS — PetMed Express Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapContrarian

Annual income statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	283	284	309	273	257
Cost of Revenue
Gross Profit	95.3	81.2	89.9	78.1	71
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	237	253	272	248	258
Operating Profit	46.2	31	37.6	25.7	-1.43
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	49.1	33.9	39.2	27.1	1.58
Provision for Income Taxes
Net Income After Taxes	37.7	25.9	30.6	21.1	0.233
Net Income Before Extraordinary Items
Net Income	37.7	25.9	30.6	21.1	0.233
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	37.7	25.9	30.6	21.1	0.233
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.84	1.29	1.52	1.04	0.084
Dividends per Share